Laryngo-Rhino-Otologie

LinksSchließen

Referenz

Fayette J, Even C, Digue L. et al.
NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group.

JCO 2019;
37 (Suppl. 15) 6083-6083

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: